TNF and atherosclerosis: The amitriptyline reduced TNF-a-induced Acid SMase/CER and MAPK activation, inhibiting TNF-induced monocyte/EC interactions while decreasing future endothelial inflammation and dysfunction which is linked to atherosclerosis.